Pharmacies & Drugstores in China - Industry Market Research Report

Revenue for the Pharmacies and Drugstores industry is expected to grow an annualized 8.4% over the five years through 2023. In 2023, industry revenue is expected to grow 11.0% to $109.2 billion. Many factors have supported the industry's development, including substantial growth in the domestic demand for drugs retailed by drugstores, relatively higher drug prices in hospitals and consumers' increased ability to self-medicate. Additionally, China's accession to the World Trade Organization in December 2001 and the subsequent foreign investment input have boosted industry growth. Government support for chain drug retailing development has also positively affected the industry. The Pharmacies and Drugstores industry in China retails both western medicine and traditional Chinese medicine, products for birth control and sexual healthcare, and other personal and pharmaceutical products. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.